Hanwha General Insurance to increase its stake in Carrot SK Telecom decides not to participate in Carrot's rights offering
Translated by Kim So-in 공개 2021-06-25 08:14:33
이 기사는 2021년 06월 25일 08:10 thebell 에 표출된 기사입니다.
Hanwha General Insurance will increase its stake in its digital non-life insurer Carrot by 5%.SK Telecom has decided not to join Carrot’s rights offering slated for Friday, industry sources said Wednesday. Forfeited shares will be acquired by Hanwha General Insurance, the largest shareholder of Carrot.
Carrot decided to carry out a 100 billion won ($88 million) rights offering last month to secure working capital. Existing shareholders will acquire shares worth 90 billion won, with T Map Mobility, a subsidiary of SK Telecom, supposed to buy shares worth 10 billion won.
Hanwha General Insurance initially planned to acquire shares worth 46.4 billion won in the rights offering, but SK Telecom’s absence has made the insurance company’s investment to 61.6 billion won. After the rights offering, Hanwha General Insurance’s stake in Carrot will increase from 51.6% to 56.6%.
STIC Investments with a 15% stake in the digital non-life insurer, Altos Ventures with 9.9%, and Hyundai Motor with 3.5% will participate in the rights offering in proportion to their shareholdings.
SK Telecom, which is currently the second largest shareholder of Carrot, will own a 10% stake in the online non-life insurer after the rights offering.
SK Telecom plans to hand its 10% stake in Carrot over to T Map Mobility in the future. Earlier this year, the boards of directors of the two companies approved T Map Mobility to purchase a 20% stake in Carrot from its parent company for 20 billion won. (Reporting by Eun-sol Lee)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- [이스트소프트는 지금]'알집' 신화로 세운 종합 ICT그룹 '경고등 켜졌다'
- '사랑의열매' OCIO, NH증권 수성 여부 촉각
- 다올운용 라인업 확대 '총력'…해외재간접 펀드 출시
- [스튜어드십코드 모니터]브이아이운용, 현대엘리 표대결서 이사회측 손들었다
- [스튜어드십코드 모니터]다올운용, 삼성전자 이사 후보 '리스크 관리 미흡'
- [성과연동 펀드판매 확산]당국 눈치보며 쉬쉬…법령해석 재확인후 '본격화' 조짐
- [동구바이오제약 신사업 전략]캐시카우만으론 역부족, 벌크업 기반 '오너 보증 차입'
- [LK삼양 뉴비기닝]그룹 오너 구본욱의 변신, 경쟁력 강화만 본다
- [루키 바이오텍 in market]김권 셀비온 대표"경쟁약 넘는 효능, 품목허가 꿈 도전"
- [Policy Radar]바이오시밀러 문턱 낮춘 유럽, 비용·경쟁 판이 바뀐다